Zhigang Li
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research 26
- Immunology top 10%
- Immune Cell Function and Interaction 18
- Infectious Diseases top 10%
- Parvovirus B19 Infection Studies 26
-
- Histiocytic Disorders and Treatments 21
-
- Vascular Malformations and Hemangiomas 11
-
- Viral-associated cancers and disorders 9
-
- Family and Disability Support Research 7
-
- Acute Lymphoblastic Leukemia research 6
- Co-authors
- Honghao MaYunze ZhaoHongyun LianLei CuiDong WangQing ZhangRui ZhangAng Wei
- Partner nations
- ChinaRussiaUnited States
In The Last Decade
Zhigang Li
59 papers receiving 632 citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Hematology 319
- Immunology 228
- Infectious Diseases 181
- Physiology 122
- Genetics 41
Countries citing papers authored by Zhigang Li
This map shows the geographic impact of Zhigang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhigang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhigang Li more than expected).
Fields of papers citing papers by Zhigang Li
This network shows the impact of papers produced by Zhigang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhigang Li. The network helps show where Zhigang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhigang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore openingbreakdown → | 2024 | 49 |
| 8 | 2023 | 12 | |
| 9 | 2023 | 15 | |
| 10 | 2023 | 16 | |
| 11 | 2023 | 17 | |
| 12 | 2023 | 0 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 8 | |
| 15 | 2021 | 13 | |
| 16 | 2021 | 3 | |
| 17 | 2021 | 4 | |
| 18 | 2020 | 5 | |
| 19 | 2019 | 1 | |
| 20 | 2017 | 1 |
About Zhigang Li
Zhigang Li is a scholar working on Hematology, Infectious Diseases and Immunology, having authored 68 papers that have together received 639 indexed citations. Recurring topics across this work include Autoimmune and Inflammatory Disorders Research (26 papers), Parvovirus B19 Infection Studies (26 papers), Histiocytic Disorders and Treatments (21 papers), Immune Cell Function and Interaction (18 papers), Vascular Malformations and Hemangiomas (11 papers), Viral-associated cancers and disorders (9 papers), Family and Disability Support Research (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). The work is most often cited by research in Hematology (319 citations), Immunology (228 citations) and Infectious Diseases (181 citations). Zhigang Li has collaborated with scholars based in China, Russia and United States. Frequent co-authors include Honghao Ma, Yunze Zhao, Hongyun Lian, Lei Cui, Dong Wang, Qing Zhang, Rui Zhang, Ang Wei, Tianyou Wang and Xiaoxi Zhao. Their work appears in journals such as Nature Communications, Blood and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.